Page 1895 - Coronavirus

Bharti Airtel posts consolidated loss before tax of Rs 7,010 crore in Q4

During the quarter, the company took an exceptional charge of Rs 7,004 crore mainly on account of the re-assessment of interest on licence fee, and spectrum usage charges (including interest on AGR).

Oil at 2-month high on Chinese demand rebound, Covid-19 vaccine hope

Futures in New York climbed as much as 13.2% on Monday. Chinese oil use is at 13 million barrels a day

WTO reforms have to factor in interests of all, says Suresh Prabhu

"WTO's reforms have to take into account the interests of all members. It has to come out with a forward-looking agenda in an inclusive manner," Prabhu said

Indian economy to contract 5-7% in FY21: Bernstein, Goldman Sachs

Analysts say the Rs 20-trn stimulus package by govt a lost opportunity

Govt may consider expanding Jan Aushadhi pathology centres to block level

Private diagnostic players' business has been hit due to lockdown; open to PPP

RBI converts less than a third of Rs 30K-crore bonds into long securities

Bond dealers said the market wanted the RBI to offer them higher coupon for the switch, as the source security is maturing just next month.

ICAI issues norms for auditors to assess going concern, key audit matters

Institute suggests engaging internal auditor or another CA in cases where physical verification of stocks is not possible for statutory auditor

Lockdown impact: Railways likely to freeze hiring, cut allowances

Rlys' traffic dropped 32% to 99.86 mt between April 1 and May 14, compared to the same period last year

Nifty Bank tanks 7% on loan recovery fears, stimulus disappointment

Credit to MSMEs, suspension of IBC proceedings weigh on sentiment

Moderna's Covid-19 vaccine shows early promise; shares soar around 20%

The data are from eight people who took part in a safety trial that kicked off in March as the global pandemic caused by the novel coronavirus was spreading.

Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US

Injectibles account for 60% of crunch; most plants under American regulator's lens the past two months have now received positive outcomes

RIL says core business has got 'demand-side shock' due to coronavirus

The company listed the pandemic as internal risks in its letter of offer for its upcoming rights issue.

All for liquidity: Watch every rupee, chase dues, and refinance debt

Refinancing high-cost debt into low-cost debt is possible, thanks to the RBI's TLTROs

SoftBank Vision Fund posts $17.7 billion loss on WeWork, Uber Technologies

Takes hit after writing down the value of investments in WeWork, Uber and others; plans to double buybacks

Oppo shuts Noida factory operations after 9 workers show signs of Covid-19

Firm resumed ops at its Greater Noida plant with 3,000 workers on May 8

Acid in the funny bone

I thought of all the books I had thought were funny and I think I have a clear idea now: Humour in print has to be cruel to be funny

SARS antibodies can block coronavirus infection, claim researchers

They experimented with 25 different types of antibodies -- which target specific protein spikes on viruses -- to see if they could prevent cells becoming infected with COVID-19

The stimulus that wasn't

The bulk of Ms Sitharaman's proposals addressed supply problems, with only occasional and cursory references to demand, mostly as an afterthought

A critical phase

While business opens, states must be ready for a spike in Covid cases

With other countries also in race, make-in-India pitch will be challenging

The government's efforts to persuade global manufacturers to divert production from China may be more difficult than it thinks